Information | Relevance | |
---|---|---|
Demographics | Sex, age, symptoms, comorbidities | Malignancy is rare in young people; denuded biopsies are concerning for CIS particularly in the setting of hematuria; renal stones, recurrent infections, indwelling catheter, and obstruction are associated with benign mimickers of urothelial cancer; |
Cystoscopy | Flat (velvety), papillary, ulceration, nodular, multiple, scar | Red velvety patches suggest CIS; pathologist may insist on deeper cuts to find papillae in an initially flat lesion; ulceration is associated with aggressive disease; Inverted papilloma and mesenchymal lesions have nodular morphology; multiple lesions should be placed in separate containers to receive each a diagnosis. |
Chronology | new/ de novo tumor, recurrent lesion, re-TURB, second look, random biopsies/follow-up | Incompletely resected tumors may hide higher grade areas, which can impact final diagnosis and stage; exclusion of a prior urothelial malignancy is a criterion for PUNLMP; de novo CIS is a rare diagnosis weather CIS on follow-up may represent residual/recurrent disease. |
Location | Precise location, particularly if bladder neck/ trigone, dome, anterior wall. | Important for follow-up (residual / recurrent) and for precise accession at cystectomy (particularly if previous complete TURB or neoadjuvant therapy); Squamous metaplasia in the female trigone is physiological; Urachal remnants and lesions are exclusive to the dome; Carcinoma in diverticula is never staged pT2; Muscularis propria have peculiar peri-orificial anatomy which may impact stage; anteriorly located tumors may be technically difficult to resect. |
Procedure | Biopsy or TURB (partial or total resection) | Incompletely resected tumors may hide higher grade areas, which can impact final diagnosis and stage. |
Previous therapies | TURB, intravesical therapy, systemic neoadjuvant therapy | Intravesical therapy is more intense in the surface (buried carcinoma phenomenon) and inflammation may produce reactive atypia; Radiation therapy can induce severe nuclear atypia, which is particularly important in flat lesions and within 12 months of last dose. |